-
Third California Vioxx Trial A No-Go; Plaintiff Berwick Drops Case Day Before Jury Selection Was To Start
Judge Victoria Chaney To Consider Status Of Upcoming California State Court Vioxx Trials At April 11, 2007 Hearing (Posted by Tom Lamb at DrugInjuryWatch.com) Plaintiff Lowell Berwick, who claimed his March 2004 heart attack…
-
FDA Orchestrates Voluntary Recall of Parkinson’s Disease Drug Permax
Action Follows News Of Studies Which Revealed Link To Serious Heart Valve Damage (Posted by Tom Lamb at DrugInjuryWatch.com) On March 29, 2007 the FDA announced that Permax as well as two generic pergolide…
-
Constipation Medication Zelnorm Linked To Apparent Increased Risk Of Heart Attacks And Strokes
Novartis Suspends Sales After FDA Determines That Risks Of Serious Side Effects Outweigh Benefits Of Zelnorm (Posted by Tom Lamb at DrugInjuryWatch.com) On March 30, 2007 the FDA announced that Novartis Pharmaceuticals Corporation had…
-
Heart Failure Drug Natrecor Fails Efficacy Part Of “Off-label” Use Study
Safety Profile Of Natrecor Continues To Be Subject Of Controversy And Debate (Posted by Tom Lamb at DrugInjuryWatch.com) The results of a large study for Johnson & Johnson’s heart failure drug Natrecor failed to…
-
Sanofi-Aventis Sends “Dear Doctor” Letter Regarding Antibiotic Ketek In Late March 2007
The Letter Concerns Black-Box Warning, Prescribing Changes, And Patient Medication Guide Announced Back In Mid-February 2007 (Posted by Tom Lamb at DrugInjuryWatch.com) On March 26, 2007 the FDA announced that a so-called "Dear Doctor"…
-
March 2007 GAO Testimony On The Effectiveness Of FDA’s Postmarket Drug Safety Monitoring
FDA’s Current Initiatives May Or May Not Address Past Shortcomings — Too Early To Tell, Still (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2007 Marcia Crosse, a representative of the U.S. Government Accountability…
